Bone Metastasis Pain, from the Bench to the Bedside

Area of Science:

• Oncology
• Pain Medicine
• Molecular Biology

Background:

• Bone metastasis is a common complication of cancer, increasing with patient longevity.
• Skeletal-related events like fractures and spinal cord compression significantly reduce quality of life.
• Cancer-induced bone pain (CIBP) affects up to 75% of patients, with limited effective treatments.

Purpose of the Study:

• To review the molecular and cellular mechanisms driving CIBP.
• To explain how cancer disrupts bone homeostasis, creating a pro-tumorigenic cycle.
• To discuss current and emerging CIBP therapies.

Main Methods:

• Review of molecular mechanisms of CIBP.
• Discussion of preclinical models for CIBP evaluation (e.g., incapacitance tester, ex vivo assays).
• Analysis of current and novel therapeutic strategies.

Main Results:

• Cancer cells induce a "vicious cycle" in bone, releasing pain mediators like protons, neurotrophins, interleukins, chemokines, and ATP.
• Preclinical models demonstrate cancer's impact on bone and pain pathways.
• Existing CIBP treatments are limited and non-specific.

Conclusions:

• Understanding CIBP's molecular basis is crucial for developing targeted therapies.
• Novel therapeutic approaches are needed to effectively manage CIBP.
• Future treatments aim to alleviate pain and improve the lives of cancer patients with bone metastases.